Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Biomedical Translational Research : Drug Design and Discovery / / edited by R.C. Sobti, Naranjan S. Dhalla
| Biomedical Translational Research : Drug Design and Discovery / / edited by R.C. Sobti, Naranjan S. Dhalla |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2022 |
| Descrizione fisica | 1 online resource (597 pages) |
| Disciplina | 610.28 |
| Soggetto topico |
Medicine - Research
Biology - Research Drugs - Design Pharmaceutical chemistry Genomics Bioinformatics Biomedical Research Structure-Based Drug Design Pharmaceutics Disseny de medicaments Enginyeria biomèdica |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-16-9232-7 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Emerging Technologies : Gateway to Understand Molecular Insight of Diseases, Newer Drugs, Their Design and Targeting -- Chapter 2. Polypharmacology: New Paradigms in Drug Development -- Chapter 3. Drug Repurposing in Biomedical Research : Benefits and Challenges -- Chapter 4. Computational Methods for Drug Repurposing -- Chapter 5. Genomic Approaches for Drug Repositioning -- Chapter 6. Organ-On-A- Chip: Novel in-Vitro Model For Drug Discovery -- Chapter 7. Precision Radiomolecular Oncology: Challenging the Classical Statistical Evidence Based Medicine -- Chapter 8. Drug Repositioning of the Phenylpiperazine Derivative Naftopidil in Prostate Cancer Treatment -- Chapter 9. Biomarker Based Drug Discovery and Reverse Translational Approach -- Chapter 10. Nanotechnology in Dentistry -- Chapter 11. Nanoparticles a Potential Breakthrough in Counteracting Multidrug-Resistant Bacterial Infections: A Holistic View on Underlying Mechanisms and Antibacterial Properties -- Chapter 12. Emerging Role of Cannabinoid System Modulators in Treatment of Cancer -- Chapter 13. Nanodrugs : A Futuristic Approach for Treating Nephrolithiasis -- Chapter 14. Lipo Dermaceuticals : Technological Transformation -- Chapter 15. The Importance of Drug Dose Adjustment in Elderly Patients with Special Considerations for Patients on Diverse Co-Medications and Antidepressants -- Chapter 16. Role of Microfluidics and Nano Fluidics in Managing CAD -- Chapter 17. Targeted Gene Delivery Through Magnetofection: The New Face of Medicine -- Chapter 18. Qbd-Steered Systematic Development of Drug Delivery Nanoconstructs : Vital Precepts, Retrospect and Prospects -- Chapter 19. Nanoemulsions: A Potential Advanced Nanocarrier Platform for Herbal Drug Delivery -- Chapter 20. Sirna Encapsulated Nanoparticles for Targeting Dorsal Root Ganglion (Drg) in Diabetic Neuropathic Pain -- Chapter 21. EGFR Targeted Quinazoline Clubbed Heterocycles as Anti-Cancer Agents. Chapter 22. Therapeutic Human Monoclonal Antibodies -- Chapter 23. Hydroxyapatites and Their Biomedical Applications -- Chapter 24. Recent Progress in Applications of Magnetic Nanoparticles in Medicine: A Review -- Chapter 25. Chimeric Antigen Receptor T-Cell Therapy: A Cutting Edge Therapy for Multiple Myeloma -- Chapter 26. Nanoparticles-Associated Lipopeptides: A New Class of Antimicrobials -- Chapter 27. Antimicrobial Applications of Engineered Metal-Based Nanomaterials -- Chapter 28. Strengthening Immunity-Ayurveda & Medicinal Plants -- Chapter 29. The Pathophysiology of Liver Disorders and Pharmacotherapy Options with Special Reference to Traditional Herbal Medicines: A Comprehensive Review -- Chapter 30. Polymeric Vehicles for Controlled Delivery of Ayurvedic Drugs for Wound Management. |
| Record Nr. | UNINA-9910585974703321 |
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Delineating health and health system : mechanistic insights into Covid 19 complications / / R. C. Sobti [and three others], editors
| Delineating health and health system : mechanistic insights into Covid 19 complications / / R. C. Sobti [and three others], editors |
| Pubbl/distr/stampa | Singapore : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (496 pages) |
| Disciplina | 616.2414 |
| Soggetto topico |
COVID-19 (Disease) - Complications
COVID-19 Complicacions (Medicina) |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-16-5105-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Biography of Prof. Nirmal Kumar Ganguly -- Preface -- Contents -- Editors and Contributors -- About the Editors -- Contributors -- 1: Corona Viruses: Emergence, Evolution, and Recurrence -- 1.1 Introduction -- 1.2 General Classification and Distribution of Corona Viruses (CoVs) -- 1.3 Structural and Genomic Features of Corona Viruses -- 1.3.1 Structural Features -- 1.3.2 Genomic Features -- 1.4 Evolution of Corona Viruses -- 1.4.1 Animal Origin of Human Corona Viruses (HcoVs) -- 1.4.2 Genetic Diversity and Possible Reasons Behind the Interspecies Transmission -- 1.4.2.1 Genetic Diversity Among Human Corona Viruses (HCoVs) -- 1.4.2.1.1 Genus AlphaCoVs -- 1.4.2.1.2 Genus BetaCoVs -- 1.4.2.2 Genomic Variability of Corona Viruses (CoVs) in Animals and Humans -- 1.5 Emergence of Corona Viruses as Human Pathogens -- 1.5.1 Pandemic Human Corona Viruses -- 1.5.2 Endemic Human Corona Viruses -- 1.6 Comparative Pathophysiology of HCoVs -- 1.6.1 Less Pathogenic Strains (229E, NL63, OC43, and HKU1) -- 1.6.2 Highly Pathogenic Strains (SARS-CoV, MERS-CoV, and SARS-CoV-2) -- 1.6.2.1 SARS-CoV -- 1.6.2.2 MERS-CoV -- 1.6.2.3 SARS -CoV2 -- 1.7 SARS-CoV-2 Variants and the Second Wave of COVID-19 -- 1.7.1 Variants of Interest -- 1.7.2 Variants of Concern -- 1.7.3 Surge of COVID-19 in 2021 -- 1.7.4 Second Wave of COVID-19 in Indian Perspective -- 1.8 Therapeutic Options, Control Measures, and Challenges -- 1.8.1 Repurposing of Drugs -- 1.8.2 Control of Corona Viral Diseases Through Vaccines -- 1.8.2.1 Whole Virus Inactivated or Killed -- 1.8.2.2 Live Attenuated Vaccines (LAV) -- 1.8.2.3 DNA Vaccines -- 1.8.2.4 Non-replicating Viral Vector Vaccines -- 1.8.2.5 Protein Subunit Vaccines -- 1.8.2.6 Virus-Like Particle (VLP) Based Vaccines -- 1.8.2.7 RNA Vaccines -- 1.9 Control Measures -- 1.10 Challenges -- 1.11 Conclusions and Future Prospects -- References.
2: Testing Strategy of Covid-19: A Mechanistic Approach -- 2.1 Introduction -- References -- 3: The Broad Impact of Infectious Disease Epidemics on Human Civilization: A Public Health Perspective -- 3.1 Introduction -- 3.2 Historical Aspects -- 3.2.1 Cholera Forcing -- 3.2.2 Technology Forcing -- 3.2.3 Scapegoating -- 3.2.4 Cholera Denial -- 3.2.5 Role of Globalization -- 3.3 Behavioural Changes in the Wake of COVID-19 -- 3.3.1 International Scenario -- 3.3.2 India/Country-Level Scenario -- 3.3.3 Community-Level Scenario -- 3.3.4 Home-Level scenario -- 3.3.5 Professional Life scenario -- 3.3.6 Health Care Sector scenario -- 3.3.7 Media scenario -- 3.3.8 Behavioural Changes in Routine Life in Various Sections of Society -- 3.3.8.1 Patients -- 3.3.8.2 High-Risk Groups -- 3.3.8.3 Doctors/Nurses/Health Care Workers (Corona Warriors) -- 3.3.8.4 Migrant Labour -- 3.3.8.5 Domestic Help -- 3.3.8.6 Children and Adolescents -- 3.3.8.7 Adults -- 3.3.8.8 Elderly and People with Disabilities -- 3.3.8.9 Scenario in Different Income Groups -- 3.3.8.9.1 Below Poverty Line (Poor People) -- 3.3.8.9.2 Middle-Class people -- 3.3.8.9.3 Upper Middle- and Upper-Class People -- 3.3.9 Impact on Different Aspects of the Life of the General Public -- 3.3.9.1 Home -- 3.3.9.2 Food -- 3.3.9.3 Shopping for Grocery -- 3.3.9.4 Entertainment -- 3.3.9.5 Work/Offices/Occupation -- 3.3.9.5.1 Permanent Employees -- 3.3.9.5.2 Loss of Job for Temporary Workers, Future Gloomy -- 3.3.9.5.3 Hospitality Industry -- 3.3.9.5.4 Conferences, Meeting, Interviews/Exams and Outings were Suspended -- 3.3.9.5.5 Work from Home -- 3.3.9.5.6 School/Colleges -- 3.3.9.5.7 Outing/Socializing -- 3.3.9.5.8 Marriages/Rituals/Functions/Ceremonies -- 3.3.9.5.9 Sleep -- 3.3.9.5.10 Mental Health Issues -- 3.3.9.5.11 Exercise -- 3.3.9.5.12 Transport and Travel -- 3.3.9.5.13 Rent/Accommodation. 3.3.9.5.14 Health care sector -- 3.3.9.5.15 Pets -- 3.3.9.5.16 Religious Places -- 3.3.10 Behavioural Economics and COVID-19 -- 3.3.11 COVID-19 Resulted in Unprecedented Job Loss -- 3.3.12 Social Impacts: Rumours and social chaos -- 3.3.13 The Pandemic Brought us Many Gains Also- -- 3.4 Role of Various Stakeholders in Corona Pandemic with a Specific Focus upon Public Health Discipline -- 3.4.1 Role of National-Level Policy-Makers/Executives/Experts -- 3.4.2 Role of Apex-Level Medical Institutions -- 3.4.3 Role of Public Health Professionals in Control of Coronavirus Crisis -- 3.4.4 Application of General Principles of Public Health -- 3.4.4.1 Level 1: Health Promotion -- 3.4.4.1.1 Ways to Improve our Societies After the Pandemic -- 3.4.4.1.2 Common-Sense Steps cities Can Take to Fight the Coronavirus -- 3.4.4.1.3 Ways to Tackle Ethical and Legal Issues in Pandemic Planning (Lemon et al. 2007) -- 3.4.4.1.4 Application of the Other Lessons Learnt -- 3.4.4.1.5 Battling Airborne Pathogens -- 3.4.4.1.6 Vaccines and Pharmaceuticals -- 3.4.4.2 Level 2: Specific Protection -- 3.4.4.3 Secondary Prevention (Level 3: Early Diagnosis and Treatment) -- 3.4.4.4 Tertiary Prevention -- 3.4.5 Public Health Professionals´ Perspectives on COVID-19 -- 3.5 Conclusions and Recommendations -- 3.5.1 Behavioural Strategies for Disease Containment and Mitigation -- 3.5.2 The Problem of Authority Needs to Be Resolved -- 3.5.3 Role of the Government and the Administrators -- 3.5.3.1 Widespread Blame Games -- 3.5.3.2 Impact of Shutdowns -- 3.5.3.3 Pandemic as an Opportunity for `Technology Forcing´ -- 3.5.3.4 One Health Concept -- 3.5.3.5 Pandemics as Collateral Damage of our Behaviour -- 3.5.3.6 Pandemics Viewed as a By-Product of International Power Game -- 3.5.3.7 Final Comments -- References -- 4: Human Impacts on Natural Habitats Leading to Covid-19 Pandemic. 4.1 Introduction -- 4.2 Human Impacts on Natural Habitats -- 4.3 Unplanned Urbanization -- 4.4 Climate Change -- 4.5 Environmental Sustainability for the Prevention of Pandemics in Future -- 4.6 Conclusion -- References -- 5: Transmission of SARS-CoV2 and Strategies for Control of Infection: Lessons Learnt -- 5.1 Introduction -- 5.2 Modes of Transmission -- 5.2.1 Epidemiological Triad of COVID-19 -- 5.2.2 Chain of Transmission -- 5.2.3 Incubation Period -- 5.3 Phases of Pandemic -- 5.4 Strategies to Break the Transmission of SARS-CoV-2 -- 5.5 Impact of Various Strategies on Different Spheres of People -- 5.6 Mortality and Comorbid Conditions Associated with COVID-19 -- 5.7 Role of Vaccine -- 5.8 Success Stories -- References -- 6: Pathogenesis of COVID-19 Infection -- 6.1 Introduction -- 6.2 Virus Entry and Spread -- 6.3 Cytokine Storm -- 6.4 Acute Respiratory Distress Syndrome (ARDS) -- 6.5 Immune Dysfunction -- References -- 7: Pathology of COVID-19 Infection -- 7.1 Introduction -- 7.2 The Pulmonary System -- 7.3 Extra Pulmonary Involvement -- 7.3.1 The Cardiovascular System -- 7.3.2 The Nervous System -- 7.3.3 Musculoskeletal System -- 7.3.4 The Liver -- 7.3.5 The Kidney -- 7.3.6 The Gastrointestinal System -- 7.3.7 The Skin -- 7.3.8 The Genital System (Testis) -- 7.3.9 The Hematopoietic System -- References -- 8: COVID-19: Clinical Spectrum-It´s Multiorgan Syndrome -- 8.1 Introduction -- 8.2 Clinical Presentation -- 8.2.1 Pulmonary Manifestations -- 8.2.2 Extrapulmonary Manifestations -- 8.2.2.1 Gastrointestinal and Liver -- 8.2.3 Renal Manifestations -- 8.2.4 Cardiac Manifestations -- 8.2.5 Vascular System -- 8.2.6 Neurologic Manifestations -- 8.2.7 Hematologic Abnormalities -- 8.2.8 Cutaneous Manifestations -- 8.2.9 Reproductive System Involvement -- 8.2.10 Ocular Manifestations -- 8.2.11 Psychiatric Manifestations -- 8.3 Special Considerations. 8.3.1 COVID-19 and Pregnancy -- 8.3.2 COVID-19 and Children -- 8.4 Conclusion -- References -- 9: Organ Involvement in COVID 19: Lung and Beyond -- 9.1 Introduction -- 9.2 Lung Involvement -- 9.3 Heart and Blood Vessels -- 9.4 Gastrointestinal Tract and Liver -- 9.5 Haematological Manifestations -- 9.6 Neurological Manifestations -- 9.7 Anosmia and Ageusia -- 9.8 Renal Involvement -- 9.9 Skin Manifestations -- 9.10 Endocrine Abnormalities -- 9.11 Ocular Manifestations -- 9.11.1 Persistent/Long COVID -- Suggested Reading -- 10: COVID-19 and Mucormycosis -- 10.1 Introduction -- 10.2 Mucormycosis -- 10.3 COVID-19 and Immunosuppression -- 10.4 Mucormycosis Coinfection in COVID-19 -- 10.5 Time of Presentation -- 10.6 Reasons for Increase in Mucormycosis in COVID-19 patients (https://dghs.gov.in/WriteReadData/News/202105171119301555988Mu... -- 10.7 Diagnosis -- 10.8 Current Management and Treatment Options for CAM -- References -- 11: Rhino-Orbito-Cerebral Mucormycosis-The Bane of the `Black Fungus´ -- 11.1 Introduction -- 11.2 Cause and Pathogenesis -- 11.3 Risk Factors -- 11.4 COVID-19 and Mucormycosis -- 11.5 Clinical Features of Rhino-Orbito-Cerebral-Mucormycosis -- 11.6 Imaging -- 11.7 Microbiological Investigations -- 11.8 Management -- 11.8.1 Medical Management -- 11.8.2 Surgical Management -- 11.8.3 Systemic Management -- 11.9 Disease Burden and Prognosis -- 11.10 Prevention -- 11.11 Conclusion -- References -- 12: Strokes, Neurological, and Neuropsychiatric Disorders in COVID-19 -- 12.1 Introduction -- 12.2 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Infection -- 12.3 The Burden of Neurological Manifestations -- 12.4 Pathogenesis of Neurological Manifestations in COVID-19 -- 12.5 Stroke in COVID-19: Risk Factors, Pathogenesis, and Clinical Manifestation -- 12.6 Neuropsychiatric Manifestations of COVID-19 -- 12.7 Summary. References. |
| Record Nr. | UNINA-9910510545403321 |
| Singapore : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug Repurposing for Emerging Infectious Diseases and Cancer / / edited by Ranbir Chander Sobti, Sunil K. Lal, Ramesh K. Goyal
| Drug Repurposing for Emerging Infectious Diseases and Cancer / / edited by Ranbir Chander Sobti, Sunil K. Lal, Ramesh K. Goyal |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (664 pages) |
| Disciplina | 905 |
| Soggetto topico |
Diseases
Therapeutics Pharmacology Oncology |
| ISBN | 981-19-5399-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Drug repurposing: an advance way to traditional drug discovery -- Chapter 2. Drug polypharmacology towards drug repurposing -- Chapter 3. Pharmacovigilance based drug repurposing -- Chapter 4. In silico analysis of cellular interactors of pqbp1 for potential drug repurposing -- Chapter 5. Drug repurposing opportunities in cancer -- Chapter 6. Repurposing of flavonoids as promising phytochemicals for the treatment of lung carcinoma -- Chapter 7. Targeted therapies used in the treatment of non-small cell lung cancer: an overvie -- Chapter 8. Targeting the ubiquitin machinery for cancer therapeutics -- Chapter 9. Repurposing of serotonin pathway influencing drugs for potential cancer therapy and antimicrobial functions -- Chapter 10. Drug repurposing for hematological malignancies -- Chapter 11. Drug repurposing for ent and head and neck infectious and oncologic diseases: current practices and future possibilities -- Chapter 12. Repurposing of immun-modulators for the treatment of cancer with qsar approaches -- Chapter 13. Reverse translational approach in repurposing of drugs for anticancer therapy -- Chapter 14. Therapeutic targeting of antineoplastic drugs in alzheimer’s disease: discovered in repurposed agents -- Chapter 15. Repurposing of drugs for the treatment of microbial diseases -- Chapter 16. Repurposing anti-inflammatory agents in the potential treatment of sars-cov-2 infection -- Chapter 17. Repurposing drugs for viruses and cancer: a novel drug repositioning strategy for covid-19 -- Chapter 18. Repurposing of serotonin pathway influencing drugs for potential cancer therapy and antimicrobial functions -- Chapter 19. Drug repurposing for covid-19 therapy: pipeline, current status and challenges -- chapter 20. Deoxy-d-glucose - a repurposed drug for covid-19 treatment -- Chapter 21. Repurposing methylene blue for the management of covid-19: prospects, paradox and perspective -- Chapter 22. Drug repurposing in covid-19 and cancer: how far have we come? -- Chapter 23.Repurposing of doxycycline to attenuate influenza virus pathogenesis via inhibition of matrix metalloproteinases in neutrophils -- Chapter 24. Therapeutic repurposing approach: new opportunity for developing drugs against covid‑19 -- chapter 25. Repurposing drugs for viruses and cancer: a novel drug repositioning strategy for covid-19 -- Chapter 26. Repurposing of therapeutic approaches for the treatment of vitiligo -- Chapter 27. Emerging infections and their management -- Chapter 28. Repurposing of minocycline, a tetracycline antibiotic, for neurodegenerative disorders. |
| Record Nr. | UNINA-9910659493603321 |
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Environmental Biotechnology: For Sustainable Future / / edited by Ranbir Chander Sobti, Naveen Kumar Arora, Richa Kothari
| Environmental Biotechnology: For Sustainable Future / / edited by Ranbir Chander Sobti, Naveen Kumar Arora, Richa Kothari |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (397 pages) |
| Disciplina | 628.5 |
| Soggetto topico |
Environmental engineering
Biotechnology Bioremediation Sustainability Refuse and refuse disposal Agriculture Microbiology Environmental Engineering/Biotechnology Waste Management/Waste Technology |
| ISBN | 981-10-7284-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910337891503321 |
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Molecular Biomarkers for Cancer Diagnosis and Therapy / / edited by Ranbir Chander Sobti, Haruhiko Sugimura, Aastha Sobti
| Molecular Biomarkers for Cancer Diagnosis and Therapy / / edited by Ranbir Chander Sobti, Haruhiko Sugimura, Aastha Sobti |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (770 pages) |
| Disciplina | 616.994075 |
| Soggetto topico |
Cancer
Tumor markers Cancer - Treatment Cancer - Genetic aspects Cancer Biology Tumour Biomarkers Cancer Therapy Cancer Genetics and Genomics Marcadors tumorals |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 9789819937462 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Molecular Biomarkers of Cancer and their Diagnostic Applications -- Chapter 2. Statistical Models in Cancer Management -- Chapter 3. Deep Learning Techniques for Computer Aided Diagnosis of Various Cancers -- Chapter 4. Machine Learning Techniques in Computer Aided Diagnosis for Effective Detection of Malignant Tissues -- Chapter 5. Molecular Mechanisms of Oncogenesis -- Chapter 6. Application of CRISPR in Cancer Research and Treatment -- Chapter 7. Nanobiosensing Platforms for Early Detection of Cancer -- Chapter 8. Bionanotechnological Strategies and Tools for Cancer Prediction, Prevention and Therapy -- Chapter 9. Central Nervous System Tumors -- Chapter 10. Biomedical Approaches in the Research and Management of Head and Neck Squamous Cell Carcinoma -- Chapter 11. Applications of Molecular Biology and Biomedical Advances in Ocular Oncology -- Chapter 12. Molecular Markers in Oral Cancer -- Chapter 13. MicroRNAs as Tools for Early Diagnosis and Predicting Response to Therapy in Oesophageal Cancer -- Chapter 14. The Role of Complement Regulatory Proteins during Liver Homeostasis and Hepatitis C Virus-related Liver Disease -- Chapter 15. Metabolite based Biosignature of Pancreatic Cancer -- Chapter 16. Molecular Pathogenesis of Lung Cancer: Evolving Landscape based on Past Experience -- Chapter 17. Molecular Insights and Risk Factors Associated with Small and Non-Small Cell Lung Cancer -- Chapter 18. Deciphering the Role of Immune-Checkpoint Inhibitors in Lung Cancer Treatment -- Chapter 19. Bone Tumors: An Overview -- Chapter 20. Genomics in the ‘Personalize’ Management of Breast Cancer -- Chapter 21. Colorectal Cancer and Role of Biomarkers in Diagnosis, Prognostification and Personalized Treatment -- Chapter 22. Biomarkers in Renal Cell Carcinoma -- Chapter 23. Androgen and Estrogen Signalling Pathways in Prostate Hyperplastic Tissues: Opportunities for Therapeutic Targeting from Multiple Angles -- Chapter 24. Role of Circadian Rhythm in Hormonal Cancers -- Chapter 25. Recent Immunotherapeutic Approaches for Cancer Treatment -- Chapter 26. Importance of Adme for Anticancer Prodrugs -- Chapter 27. Personalized Medicine in Clinical Management of Breast Cancer - Where Do We Stand? -- Chapter 28. PABPC1: A Novel Emerging Target for Cancer Prognostics and Anti-Cancer Therapeutics -- Chapter 29. Recent Update on Pyridoxine Derivatives as Anticancer Agents with Overview on its Patents -- Chapter 30. Recent Advances in Iron Oxide Nanoparticles-based Nano Medicine for Prostate Cancer: A Review -- Chapter 31. Therapeutic Applications of Snake Venom Proteins as Anti-Cancer Agents -- Chapter 32. Revamping Anticancer Strategies by Modulating Tumor Microenvironment using Botanicals -- Chapter 33. Modulation of Epigenetic Regulators for Cancer Prevention by Dietary Phytochemicals: Tools for Personalized Nutrition. |
| Record Nr. | UNINA-9910869175103321 |
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||